160 related articles for article (PubMed ID: 7856858)
1. Development of a high-performance liquid chromatographic method for the analysis of enatiomer/enantiomer interaction in oxidative metabolism of bunitrolol in rat liver microsomes.
Narimatsu S; Huang Y; Mizukami T; Masubuchi Y; Suzuki T
Anal Biochem; 1994 Oct; 222(1):256-61. PubMed ID: 7856858
[TBL] [Abstract][Full Text] [Related]
2. In-vitro metabolic interaction of bunitrolol enantiomers in rabbit liver microsomes.
Narimatsu S; Mizukami T; Huang Y; Masubuchi Y; Suzuki T
J Pharm Pharmacol; 1996 Nov; 48(11):1185-9. PubMed ID: 8961170
[TBL] [Abstract][Full Text] [Related]
3. Purification and characterization of a cytochrome P-450 isozyme catalyzing bunitrolol 4-hydroxylation in liver microsomes of male rats.
Suzuki T; Narimatsu S; Fujita S; Masubuchi Y; Umeda S; Imaoka S; Funae Y
Drug Metab Dispos; 1992; 20(3):367-73. PubMed ID: 1355709
[TBL] [Abstract][Full Text] [Related]
4. Stereoselectivity in bunitrolol 4-hydroxylation in liver microsomes from marmosets and Japanese monkeys.
Narimatsu S; Gotoh M; Masubuchi Y; Horie T; Ohmori S; Kitada M; Kageyama T; Asaoka K; Yamamoto I; Suzuki T
Biol Pharm Bull; 1996 Nov; 19(11):1429-33. PubMed ID: 8951158
[TBL] [Abstract][Full Text] [Related]
5. Enantioselectivity of bunitrolol 4-hydroxylation is reversed by the change of an amino acid residue from valine to methionine at position 374 of cytochrome P450-2D6.
Narimatsu S; Kato R; Horie T; Ono S; Tsutsui M; Yabusaki Y; Ohmori S; Kitada M; Ichioka T; Shimada N; Kato R; Ishikawa T
Chirality; 1999; 11(1):1-9. PubMed ID: 9914647
[TBL] [Abstract][Full Text] [Related]
6. Effect of 3-methylcholanthrene on bunitrolol metabolism. Kinetics and immunological studies on 4-hydroxylation of bunitrolol catalyzed by two species of cytochromes P450 in rat liver microsomes.
Fujita S; Masuda M; Shimamoto Y; Hoshi H; Kariya S; Kazusaka A; Suzuki T
Drug Metab Dispos; 1996 Feb; 24(2):254-9. PubMed ID: 8742239
[TBL] [Abstract][Full Text] [Related]
7. Purification and characterization of a dog cytochrome P450 isozyme belonging to the CYP2D subfamily and development of its antipeptide antibody.
Nakamura A; Yamamoto Y; Tasaki T; Sugimoto C; Masuda M; Kazusaka A; Fujita S
Drug Metab Dispos; 1995 Nov; 23(11):1268-73. PubMed ID: 8591729
[TBL] [Abstract][Full Text] [Related]
8. Stereoselective metabolism of cibenzoline, an antiarrhythmic drug, by human and rat liver microsomes: possible involvement of CYP2D and CYP3A.
Niwa T; Shiraga T; Mitani Y; Terakawa M; Tokuma Y; Kagayama A
Drug Metab Dispos; 2000 Sep; 28(9):1128-34. PubMed ID: 10950860
[TBL] [Abstract][Full Text] [Related]
9. Oxidation of R(+)- and S(-)-carvedilol by rat liver microsomes. Evidence for stereoselective oxidation and characterization of the cytochrome P450 isozymes involved.
Fujimaki M
Drug Metab Dispos; 1994; 22(5):700-8. PubMed ID: 7835220
[TBL] [Abstract][Full Text] [Related]
10. Species differences for stereoselective metabolism of ethofumesate and its enantiomers in vitro.
Zhu W; Dang Z; Qiu J; Liu Y; Lv C; Diao J; Zhou Z
Xenobiotica; 2009 Sep; 39(9):649-55. PubMed ID: 19552529
[TBL] [Abstract][Full Text] [Related]
11. Enantioselective aliphatic hydroxylations of racemic 1-hydroxy-3-methylcholanthrene by rat liver microsomes.
Shou MG; Yang SK
Chirality; 1990; 2(3):141-9. PubMed ID: 2252843
[TBL] [Abstract][Full Text] [Related]
12. Inactivation of rat cytochrome P450 2D enzyme by a further metabolite of 4-hydroxypropranolol, the major and active metabolite of propranolol.
Narimatsu S; Arai T; Masubuchi Y; Horie T; Hosokawa M; Ueno K; Kataoka H; Yamamoto S; Ishikawa T; Cho AK
Biol Pharm Bull; 2001 Sep; 24(9):988-94. PubMed ID: 11558582
[TBL] [Abstract][Full Text] [Related]
13. Involvement of a cytochrome P4502D subfamily in human liver microsomal bunitrolol 4-hydroxylation.
Narimatsu S; Masubuchi Y; Hosokawa S; Ohmori S; Kitada M; Suzuki T
Biol Pharm Bull; 1994 Jun; 17(6):803-7. PubMed ID: 7951142
[TBL] [Abstract][Full Text] [Related]
14. High-performance liquid chromatographic analysis of the sulfation of 4-hydroxypropranolol enantiomers by monkey liver cytosol.
Narimatsu S; Kobayashi N; Asaoka K; Masubuchi Y; Horie T; Hosokawa M; Ishikawa T; Ohmori S; Kitada M; Miyano J; Kataoka H; Yamamoto S
Chirality; 2001; 13(3):140-7. PubMed ID: 11270323
[TBL] [Abstract][Full Text] [Related]
15. Determination of zolmitriptan enantiomers in rat liver microsomes by chiral high performance liquid chromatography with fl uorescence detection.
Yu L; Yao T; Ni S; Zeng S
Biomed Chromatogr; 2005 Apr; 19(3):191-5. PubMed ID: 15484224
[TBL] [Abstract][Full Text] [Related]
16. Metabolism of prazepam by rat liver microsomes: stereoselective formation and N-dealkylation of 3-hydroxyprazepam.
Lu XL; Yang SK
Mol Pharmacol; 1989 Dec; 36(6):932-8. PubMed ID: 2601688
[TBL] [Abstract][Full Text] [Related]
17. Imipramine-induced inactivation of a cytochrome P450 2D enzyme in rat liver microsomes: in relation to covalent binding of its reactive intermediate.
Masubuchi Y; Igarashi S; Suzuki T; Horie T; Narimatsu S
J Pharmacol Exp Ther; 1996 Nov; 279(2):724-31. PubMed ID: 8930177
[TBL] [Abstract][Full Text] [Related]
18. Liquid chromatographic-electrospray mass spectrometric determination (LC-ESI-MS) of phase II metabolites of flobufen in rat liver microsomes-Chiral discrimination.
Babú YN; Nemec M; Solich P; Wsól V
Talanta; 2008 Apr; 75(2):494-502. PubMed ID: 18371912
[TBL] [Abstract][Full Text] [Related]
19. Stereoselective metabolism of prazepam and halazepam by human liver microsomes.
Lu XL; Guengerich FP; Yang SK
Drug Metab Dispos; 1991; 19(3):637-42. PubMed ID: 1680631
[TBL] [Abstract][Full Text] [Related]
20. Substrate stereoselectivity and enantiomer/enantiomer interaction in propranolol metabolism in rat liver microsomes.
Masubuchi Y; Yamamoto LA; Uesaka M; Fujita S; Narimatsu S; Suzuki T
Biochem Pharmacol; 1993 Nov; 46(10):1759-65. PubMed ID: 8250961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
